WMRU
RAPT

William Marsh Rice University’s RAPT Therapeutics RAPT Stock Holding History

William Marsh Rice University’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,508
Closed -$384K – 6
2021
Q2 		$384K Sell
1,508
-273
-15% -$51K 0.17% 4
2021
Q1 		$316K Hold
1,781
– – 0.17% 5
2020
Q4 		$281K Buy
+1,781
New +$387K 0.21% 3

Other funds holding RAPT

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Marsh Rice University's RAPT Position: Q3 2021 in Review

William Marsh Rice University sold out of RAPT Therapeutics (RAPT) in Q3 2021, closing a stake of 1,508 shares — an estimated $384K sold.

William Marsh Rice University first reported a position in RAPT in Q4 2020 and held it in 3 quarters. The position peaked at $384K in Q2 2021. 106 funds tracked by Wall St. Rank hold RAPT as of Q3 2021.

  • William Marsh Rice University reported no remaining RAPT Therapeutics position as of Q3 2021 after selling out during the quarter.
  • William Marsh Rice University sold 1,508 RAPT Therapeutics shares in Q3 2021, an estimated $384K.
  • William Marsh Rice University first reported a position in RAPT Therapeutics in Q4 2020 and held it in 3 quarters.
  • William Marsh Rice University's RAPT Therapeutics position peaked at $384K in Q2 2021.
  • 106 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q3 2021.

Based on William Marsh Rice University's 13F filing for Q3 2021, filed 21 Oct 2021.